Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Ayahuasca and Its DMT- and beta-carbolines - Containing Ingredients Block the Expression of Ethanol-Induced Conditioned Place Preference in Mice: Role of the Treatment Environment

Texto completo
Autor(es):
Mostrar menos -
Cata-Preta, Elisangela G. [1] ; Serra, Yasmim A. [1] ; Moreira-Junior, Eliseu da C. [1] ; Reis, Henrique S. [1] ; Kisaki, Natali D. [1] ; Libarino-Santos, Matheus [1] ; Silva, Raiany R. R. [1] ; Barros-Santos, Thaisa [1] ; Santos, Lucas C. [1] ; Barbosa, Paulo C. R. [2] ; Costa, Jose L. [3] ; Oliveira-Lima, Alexandre J. [1] ; Berro, Lais F. [4] ; Marinho, Eduardo A. V. [1]
Número total de Autores: 14
Afiliação do(s) autor(es):
[1] Univ Estadual Santa Cruz, Dept Hlth Sci, Ilheus - Brazil
[2] Univ Estadual Santa Cruz, Dept Philosophy & Human Sci, Ilheus - Brazil
[3] Univ Estadual Campinas, Fac Pharmaceut Sci, Campinas, SP - Brazil
[4] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 - USA
Número total de Afiliações: 4
Tipo de documento: Artigo Científico
Fonte: FRONTIERS IN PHARMACOLOGY; v. 9, MAY 29 2018.
Citações Web of Science: 5
Resumo

Ayahuasca is a hallucinogenic beverage produced from the decoction of Banisteriopsis caapi (Bc) and Psychotria viridis (Pv), beta-carboline- and N,N-dimethyltryptamine(DMT)-containing plants, respectively. Accumulating evidence suggests that ayahuasca may have therapeutic effects on ethanol abuse. It is not known, however, whether its effects are dependent on the presence of DMT or if non-DMT-containing components would have therapeutic effects. The aim of the present study was to investigate the rewarding properties of ayahuasca (30, 100, and 300 mg/kg, orally), Bc (132, 440, and 1320 mg/kg, orally) and Pv (3.75, 12.5 and 37.5 mg/kg, i.p.) extracts and their effects on ethanol (1.8 g/kg, i.p.) reward using the conditioned place preference (CPP) paradigm in male mice. Animals were conditioned with ayahuasca, Bc or Pv extracts during 8 sessions. An intermediate, but not a high, dose of ayahuasca induced CPP in mice. Bc and Pv did not induce CPP. Subsequently, the effects of those extracts were tested on the development of ethanol-induced CPP. Ayahuasca, Bc or Pv were administered before ethanol injections during conditioning sessions. While Bc and Pv exerted no effects on ethanol-induced CPP, pretreatment with ayahuasca blocked the development of CPP to ethanol. Finally, the effects of a post-ethanol-conditioning treatment with ayahuasca, Bc or Pv on the expression of ethanol-induced CPP were tested. Animals were conditioned with ethanol, and subsequently treated with either ayahuasca, Bc or Pv in the CPP environment previously associated with saline or ethanol for 6 days. Animals were then reexposed to ethanol and ethanol-induced CPP was quantified on the following day. Treatment with all compounds in the ethanol-paired environment blocked the expression of ethanol-induced CPP. Administration of an intermediate, but not a high, dose of ayahuasca and Bc, as well as Pv administration, in the saline-paired compartment blocked the expression of ethanol-induced CPP. The present study sheds light into the components underlying the therapeutic effects of ayahuasca on ethanol abuse, indicating that ayahuasca and its plant components can decrease ethanol reward at doses that do not exert abuse liability. Importantly, the treatment environment seems to influence the therapeutic effects of ayahuasca and Bc, providing important insights into clinical practice. (AU)

Processo FAPESP: 15/10650-8 - Estudo da estabilidade de fármacos, drogas de abuso e praguicidas em amostras de sangue seco em papel, e sua aplicação na toxicologia forense
Beneficiário:José Luiz da Costa
Modalidade de apoio: Auxílio à Pesquisa - Regular